L. Knoops
Impact in
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Genetics 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 3
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Francisco Cervantes (1 shared paper)Mari McQuitty (1 shared paper)Viktoriya Stalbovskaya (1 shared paper)Kang Sun (1 shared paper)Haifa Kathrin Al‐Ali (1 shared paper)Heinz Gisslinger (1 shared paper)P. Gopalakrishna (1 shared paper)Alessandro M. Vannucchi (1 shared paper)
- Journals
- Haematologica (4 papers)Oncogene (2 papers)Leukemia (1 paper)Annals of Oncology (1 paper)Acta Clinica Belgica (4 papers)
- Partner nations
- BelgiumFranceUnited Kingdom
In The Last Decade
L. Knoops
13 papers receiving 645 citations
L. Knoops's Hit Papers
Peers
Comparison fields: 5 of 51
- Genetics 428
- Hematology 283
- Rheumatology 145
- Oncology 124
- Molecular Biology 235
Countries citing papers authored by L. Knoops
This map shows the geographic impact of L. Knoops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Knoops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Knoops more than expected).
Fields of papers citing papers by L. Knoops
This network shows the impact of papers produced by L. Knoops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Knoops. The network helps show where L. Knoops may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Knoops, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis Hit paper breakdown → | 2016 | 361 |
| 2 | 2012 | 64 | |
| 3 | 2011 | 55 | |
| 4 | 2015 | 46 | |
| 5 | 2012 | 40 | |
| 6 | 2007 | 35 | |
| 7 | 2014 | 32 | |
| 8 | 2014 | 6 | |
| 9 | 2008 | 4 | |
| 10 | 2014 | 4 | |
| 11 | 2002 | 3 | |
| 12 | Real-world data from 54 Belgian patients from the ponatinib named patient programme (NPP) | 2016 | 1 |
| 13 | Practical management of Chronic Myeloid Leukemia in Belgium | 2015 | 1 |
About L. Knoops
L. Knoops is a scholar working on Genetics, Hematology, Molecular Biology, Rheumatology and Pathology and Forensic Medicine, having authored 13 papers that have together received 652 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Kruppel-like factors research (2 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Genetics (428 citations), Hematology (283 citations), Rheumatology (145 citations), Oncology (124 citations) and Molecular Biology (235 citations). L. Knoops has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Francisco Cervantes, Mari McQuitty, Viktoriya Stalbovskaya, Kang Sun, Haifa Kathrin Al‐Ali, Heinz Gisslinger, P. Gopalakrishna, Alessandro M. Vannucchi, Claire Harrison and Tiziano Barbui. Their work appears in journals such as Haematologica, Oncogene, Leukemia, Annals of Oncology and Acta Clinica Belgica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.